What Series B Investors Look At When They Open Your Data Room

The Bar Has Moved - And Founders Are Still Using Old Numbers

The ARR threshold investors expected at Series B four or five years ago was $2-4 million. That number is gone. The current floor sits at $5-7 million ARR, with top-tier companies coming in at $10 million or above, according to current practitioner benchmarks.

I see it constantly - founders still calibrating to the old bar. They hit $4 million ARR, feel confident, start outreach, and get silence. The bar moved. They did not.

This article lays out the Series B metrics investors are using to make decisions right now - what the thresholds are, which numbers carry the most weight, and where founders consistently leave points on the table.

ARR Is the Anchor. Growth Rate Is the Story.

ARR gets a company in the room. Growth rate determines whether anyone leans forward.

Investors want to see $5-20 million in ARR with year-over-year growth of 2-3x. The companies that raise on the best terms are typically at $8-10 million ARR and growing at least 100% year-over-year. Below that, investors start asking harder questions about whether the growth engine is founder-driven.

For monthly MRR growth, the benchmarks break down clearly by stage. At Series B, best-in-class is 5-8% month-over-month. Solid is 3-5%. Below 3% needs an explanation before anyone writes a check.

The T2D3 framework - triple ARR for two consecutive years, then double for three - is the informal standard investors use when sizing up growth-stage companies. Not every company needs to hit it exactly, but it shapes expectations for what the trajectory should look like from Series A forward.

One more thing ARR alone does not show: whether the revenue is clean. Multi-year contracts with recognizable logos carry more weight than month-to-month SMB revenue at the same dollar amount. Investors do not just count dollars. They count the quality of those dollars.

Net Revenue Retention - The Metric That Determines Your Multiple

If there is one number that changes how a Series B conversation feels before it even starts, it is NRR.

NRR tells investors whether your existing customers make the business stronger over time or just keep it alive. A company with 90% NRR is fighting to stay flat. A company with 120% NRR is compounding without spending another dollar on acquisition.

The current benchmarks: 100-115% NRR is acceptable. 115-125% is strong. Above 125% is where investors start talking about premium multiples. The median NRR across private B2B SaaS has compressed to around 101%, with top performers maintaining 111% or higher.

Gross Revenue Retention matters too. At Series B, investors want to see GRR above 80-90%. Companies with GRR in the 85-90% range have been exiting at roughly 5x in M&A scenarios. Gross retention below 85% for a $5-20M ARR company is a red flag that will come up in diligence.

I see this constantly with founders I talk to: NRR is the single most predictive signal of whether your product has earned its place in customers' workflows. Investors know this. If your NRR is soft, no amount of top-line growth narrative fixes it.

Burn Multiple - The Efficiency Test That Replaced the Blitz Mindset

The era of growth-at-any-cost is over. Investors now run a burn multiple check before they get excited about growth rate.

The burn multiple is net burn divided by net new ARR. It tells you how many dollars you are spending to generate each dollar of new recurring revenue. The thresholds are clear:

• Below 1.0 - elite efficiency
• 1.0 to 1.5 - solid and fundable
• 1.5 to 2.0 - acceptable with a strong growth story
• Above 2.0 - investors start asking whether growth is being bought rather than built

This matters more at Series B than at Series A. By Series B, capital is supposed to accelerate a system that already works. If you are still spending heavily just to discover what works, that is a Series A problem you have not solved.

Early-stage companies often run burn multiples near 3.4 - spending $3.40 for every dollar of new ARR. By the $25-50 million ARR range, well-run companies get this down to around 1.4. If you are raising Series B at a 3.0+ burn multiple without a genuinely exceptional growth rate, the conversation will be hard.

CAC Payback and LTV - The Unit Economics Investors Stress-Test

Investors do not just look at your CAC payback number. They look at whether the number is honest.

The current industry-wide median CAC payback period has stretched to 18 months, per Benchmarkit's research. But for growth-stage companies targeting a strong Series B, the target is under 12 months. Product-led growth companies often hit 6-12 month payback because their sales costs are lower. Sales-led enterprise companies can run 18-24 months but need to compensate with higher ACV and lower churn.

The LTV:CAC ratio has a clear floor: 3:1 is the minimum. Below that, unit economics are functionally broken. The operating target for a Series B company is 5:1, with strong performers hitting 8:1 or above. The Artemis Fund benchmarks put LTV:CAC above 5x as the threshold for top-tier Series B companies.

One mistake that surfaces constantly: founders calculate LTV without accounting for gross margin. The honest formula is gross-margin-adjusted LTV divided by fully-loaded CAC. If your CS team drives expansion revenue, their costs belong in the LTV calculation. If your sales engineering team closes deals, their costs belong in CAC. Investors will reclassify these expenses in diligence regardless.

A useful practitioner signal here: when one B2B platform operator ran campaigns targeting different ICP segments - Data Scientists, Computer Vision engineers, and Machine Learning specialists - the results varied dramatically by segment. Open rates ranged from 50% to 75% depending on targeting precision, but meetings booked and closes came from segments where the product fit was tightest, not from the segments with the best open rates. The lesson translates directly to CAC: broad targeting produces worse unit economics than a tight ICP, even when top-of-funnel volume looks impressive.

Gross Margin - The Structural Ceiling on Everything

Gross margin determines the upper limit on what your business can become. Low gross margins cap your ability to invest in sales, marketing, and R&D as you scale. Series B investors know this.

The targets for SaaS at Series B: 70%+ is the minimum to be fundable. 75-85% is strong. Top performers from The Artemis Fund benchmarks exceed 85%, which creates the most room for reinvestment in growth.

The overall gross margin median across private SaaS companies is approximately 77%, according to Benchmarkit's data. If your gross margin is below 70%, investors will flag a cost structure problem. The question they ask is not just where the margin is today, but whether it improves as you scale.

AI-native companies are an interesting exception here. Bessemer Venture Partners data shows that scaling AI companies average a 25% gross margin - a structural difference from traditional SaaS that investors factor in when evaluating AI-forward Series B candidates. If your product has significant AI inference costs baked in, that context needs to be part of your narrative before investors raise it.

The Rule of 40 - What It Means at Series B

The Rule of 40 combines your ARR growth rate and EBITDA margin. If they add up to 40 or above, the business is considered healthy. Below 25 with no clear improvement path is a conversation-stopper with growth equity investors.

At the Series B stage, hitting Rule of 40 puts you in the top tier. A score between 25-39 is competitive but requires explanation. Companies consistently exceeding 40 tend to command significantly higher revenue multiples - research from Meritech Capital shows public SaaS cohorts scoring above 40 trade at 12-15x EV/Revenue versus roughly 6x for the broad median.

There is an important nuance: only about 9% of companies with less than $30 million in ARR beat the Rule of 40, according to BCG's benchmark of more than 100 private SaaS companies. So missing the threshold is not automatically disqualifying - but you need a credible path to getting there.

One operator who coaches founders on their metrics notes that Rule of 40 often comes up in the first 15 minutes of a Series B investor call. The founders who fumble it - or cite a number built on the wrong inputs - lose credibility immediately. Use EBITDA margin or free cash flow margin consistently. Do not mix methods between periods or rounds.

Valuation Multiples - What the Market Is Paying

Series B pre-money valuations typically range from $50 million to $200 million, with significant variation by sector and growth profile.

For B2B SaaS companies, valuation multiples depend heavily on growth rate and efficiency. Companies growing 200%+ can command 12-18x ARR multiples. Companies growing 120-150% typically receive 6-10x multiples. NRR strength of 130%+ can add a 2-4x multiple premium on its own.

The broader software market has normalized after the correction. EV/Revenue multiples for private software companies stabilized around 2.6x through most of the last two years, with a modest uptick to 3.1x in the second half of the most recent reported period, per Aventis Advisors data. The era of 20-40x ARR multiples for private Series B companies is not coming back in the near term.

EV/EBITDA multiples are becoming increasingly relevant as profitability improves across the sector. Median EBITDA margins across public SaaS reached 9.3% in recent quarters. Investors are beginning to apply earnings-based frameworks to SaaS valuations in ways they never did before. If your company has a credible path to 15%+ EBITDA margins within 12-18 months post-raise, that story is worth telling explicitly.

Customer Concentration and the Metrics Investors Rarely Discuss Publicly

Series B investors look at things that do not always appear in benchmark reports.

Customer concentration is one of them. Keep any single customer below 10-15% of your revenue. Above that threshold, investors start modeling what happens if that customer churns or renegotiates. Even if the customer seems locked in, the concentration risk changes the risk profile of the entire business.

Revenue predictability matters as much as revenue size. Spiky growth driven by one channel, one deal, or one founder-led sales motion does not de-risk the business. It concentrates risk. Investors want to see that growth is becoming more stable over time - not just bigger.

ARR per employee is another number investors check before the meeting. The benchmark for growth-stage SaaS companies is $150,000-$250,000 ARR per employee. For scale-stage companies at $30 million+ ARR, top-quartile performers hit $300,000+. If your ARR per employee is declining quarter-over-quarter, it signals you are hiring ahead of revenue - something investors spot immediately.

Sales cycle consistency matters too. Investors want to see stable conversion rates and predictable close times across your sales team - not a pattern where the founders close everything and junior reps struggle. A common reason Series A momentum stalls is that sales still run through the founders. By Series B, the GTM motion needs to be transferable.

How to Find the Customers Behind These Metrics

Series B-stage companies need pipeline that supports their growth narrative. If your story is 2x ARR growth, your pipeline coverage needs to show that is achievable with or without founder involvement in every deal.

For B2B companies targeting specific buyer profiles - mid-market CTOs, VP of Engineering, CFOs at companies with 100-500 employees - building that pipeline systematically is where I see teams leave the most money on the table. Tools like ScraperCity let you search millions of contacts by title, industry, location, and company size to build targeted outreach lists that match your ICP exactly - which directly compresses CAC and improves the unit economics that Series B investors scrutinize most.

The Metrics That Matter Most - A Quick Reference

What Separates Funded From Passed

I see it repeatedly - Series B raises failing not on absolute metrics, but because the story those metrics tell does not hold together.

An investor sees $8 million ARR but notices NRR at 95%. That means the business is losing ground in its existing customer base even as it adds new customers. The growth rate looks fine. The underlying health does not.

Or a founder shows 150% year-over-year growth but a burn multiple of 3.5. The investor calculates that the company is spending $3.50 for every dollar of new ARR. It is bought, not built.

The companies that raise cleanly are the ones where growth, retention, efficiency, and team capability all point in the same direction. When those four things reinforce each other, fundraising becomes a confirmation exercise. When they do not, no deck fixes it.

Know which metrics you are strong on before any investor conversation. Lead with those numbers. For the weaker ones, have clear explanations ready - including what you are doing about them and what the trend looks like over the last three to four quarters. Investors are not looking for flawless businesses. They are looking for businesses that feel inevitable.